Q3 2023 GeoVax Labs Inc Earnings Call Transcript
Good afternoon and welcome, everyone to the GeoVax Third Quarter 2023 corporate update call. My name is Mandy, and I will facilitate today's call. With me are David Dodd, Chairman and CEO; Mark Reynolds, Chief Financial Officer; Kelly McKee MD, MPH, Chief Medical Officer; and John Sharkey, PhD, Vice President Business Development.
(Operator Instructions) As a reminder, this conference is being recorded. At this time, I turn the call over to Max Gadicke of Stern IR. please note the following.
Thank you. Please note the following. Certain statements in this presentation may constitute forward-looking statements within the meanings of the Private Securities Litigation Reform Act. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances.
Actual results may differ materially from those included in these statements due to a variety of factors, including weather GeoVax can develop and manufacture its product candidates with the desired
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |